Trial Profile
Continuous infusion nesiritide in chronic heart failure-University of Chicago (CINCH-UC)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary)
- Indications Decompensated heart failure
- Focus Therapeutic Use
- Acronyms CINCH-UC
- 24 Mar 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 30 Oct 2005 New trial record.